Ozempic and semaglutide risks with dental anesthesia and sedation
Semaglutide and other GLP-1 receptor agonists delay gastric emptying, creating concern for retained gastric contents and aspiration during deep dental sedation or general anaesthesia. Journal of Clinical Me…For dental procedures requiring sedation, perioperative management should be coordinated with the anaesthesia team and prescriber under current institutional protocols; current guidance is risk-stratified, with most patients able to continue therapy while higher-risk patients may require a 24-hour liquid diet, anaesthetic-plan modification, and gastric ultrasound when indicated. Journal of Clinical Me…A specific medication-holding interval for GLP-1 receptor agonists is not established by a complete evidence base. Journal of Clinical Me…
Supporting sources
Inspect the exact passages
1Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based TherapiesBijoch J · Journal of Clinical Medicine · 2026Narrative review
10. Perioperative and Sedation Considerations
Because GLP-1 RAs delay gastric emptying, they raise concern for retained gastric contents and aspiration during sedation or general anaesthesia, a consideration directly relevant to dental procedures requiring deep sedation or general anaesthesia. Guidance has evolved. The 2023 American Society of Anesthesiologists (ASA) consensus recommended holding weekly agents for one week and daily agents on the day of the procedure [33]. In October 2024, updated multi-society guidance (ASA with the American Gastroenterological Association, the American Society for Metabolic and Bariatric Surgery, and others) shifted towards a more permissive, risk-stratified stance: most patients may continue their agent, with higher-risk patients following a 24 h liquid diet, anaesthetic plan modification, and point-of-care gastric ultrasound where concern exists. Dental practitioners arranging sedation should therefore coordinate with the anaesthesia team and prescriber and follow current institutional protocols, recognising that the evidence base for any specific holding interval remains incomplete [34].
What this supports
- Semaglutide and other GLP-1 receptor agonists delay gastric emptying, creating concern for retained gastric contents and aspiration during deep dental sedation or general anaesthesia.
- For dental procedures requiring sedation, perioperative management should be coordinated with the anaesthesia team and prescriber under current institutional protocols; current guidance is risk-stratified, with most patients able to continue therapy while higher-risk patients may require a 24-hour liquid diet, anaesthetic-plan modification, and gastric ultrasound when indicated.
- A specific medication-holding interval for GLP-1 receptor agonists is not established by a complete evidence base.
Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies. © 2026 by the author. Creative Commons Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/).
Answers built on the same research
Ask this against the live evidence.
You are reading a stored answer. Run the search yourself for the current evidence, or ask a follow-up about your case.
This answer was generated only from the cited passages. Clinical applicability has not been independently reviewed.
Use professional judgment and inspect the cited primary sources before clinical use.
Source inclusion does not imply endorsement of a clinical conclusion.
We generated this answer on .